Scilex Holding Company
SCLXAnalyst Consensus
Rating Trend
Recent Rating Actions
| Firm | Action | Rating | Date |
|---|---|---|---|
| D. Boral Capital | downgrade | Buy →Hold | Apr 11, 2025 |
| D. Boral Capital | maintain | Buy | Apr 2, 2025 |
| D. Boral Capital | maintain | Buy | Feb 28, 2025 |
| HC Wainwright & Co. | maintain | Buy | Oct 21, 2024 |
| HC Wainwright & Co. | maintain | Buy | Jun 17, 2024 |
| HC Wainwright & Co. | maintain | Buy | Jun 11, 2024 |
| HC Wainwright & Co. | maintain | Buy | May 23, 2024 |
| HC Wainwright & Co. | maintain | Buy | May 3, 2024 |
| HC Wainwright & Co. | maintain | Buy | Dec 4, 2023 |
Earnings History
Next report: Dec 2, 2026 · EPS est. $-0.08| Report Date | EPS Actual | EPS Est. | Revenue Actual | Revenue Est. |
|---|---|---|---|---|
| Aug 14, 2026 | $-16.65 | $-0.18 | $7.6M | $16.0M |
| May 20, 2026 | $-4.76 | $-0.21 | $8.6M | $15.0M |
| Apr 10, 2026 | $-4.60 | $-0.29 | $4.8M | $12.1M |
| Nov 14, 2025 | $-13.80 | $-13.80 | $10.6M | $10.6M |
| Aug 12, 2025 | $-4.62 | $-0.57 | $9.9M | $26.3M |
| May 14, 2025 | $-2.26 | $-4.20 | $5.0M | $5.0M |
| Mar 31, 2025 | $-0.02 | $-0.10 | $14.9M | $17.8M |
| Mar 17, 2025 | $-2.18 | $-0.10 | $14.4M | $17.9M |
News
Shares of Datavault AI Inc. (NASDAQ:DVLT) fell nearly 40% after the company told investors to stop relying on financial results stretching back to the third quarter of 2025.
Sanofi (NASDAQ: SNY - Get Free Report) and Scilex (NASDAQ: SCLX - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings. Earnings and Valuation This table compares Sanofi and Scilex"s top-line
Scilex (NASDAQ: SCLX - Get Free Report) and Iterum Therapeutics (NASDAQ: ITRM - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings. Profitability This table compares Scilex and Iterum Therapeutics'
Scilex (NASDAQ: SCLX - Get Free Report) and Incannex Healthcare (NASDAQ: IXHL - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings and dividends. Analyst Recommendations This is a breakdown of recent